Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-09), Concord Medical Services Holdings's 3-1 Month Momentum % is N/A%.
FRA:C2C's 3-1 Month Momentum % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -2.945 * Ranked among companies with meaningful 3-1 Month Momentum % only.
Concord Medical Services Holdings (FRA:C2C) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Concord Medical Services Holdings 3-1 Month Momentum % Related Terms
FRA:C2C vs GBCS, ADIA, EHSI: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Concord Medical Services Holdings's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Medical Services Holdings 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Concord Medical Services Holdings's 3-1 Month Momentum % falls into.
Concord Medical Services Holdings (FRA:C2C) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Services Holdings (FRA:C2C) has a 3-1 Month Momentum % of N/A% as of Aug. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Concord Medical Services Holdings and its competitors. According to the industry distribution chart, Concord Medical Services Holdings ranks #416 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 61.7%.
Is Concord Medical Services Holdings' 3-1 Month Momentum % too high?
Concord Medical Services Holdings' current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Concord Medical Services Holdings ranks #416 out of 674 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Concord Medical Services Holdings has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Services Holdings' 3-1 Month Momentum % compare to GBCS and ADIA?
According to the Healthcare Providers & Services industry distribution chart, Concord Medical Services Holdings ranks #416 out of 674 companies for 3-1 Month Momentum %. This places Concord Medical Services Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Concord Medical Services Holdings and its competitors. Concord Medical Services Holdings's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Services Holdings stock overvalued right now?
Concord Medical Services Holdings (FRA:C2C) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is €9.51, compared to a current price of €6.25 — trading 34.3% below its estimated fair value. The current 3-1 Month Momentum % is N/A%. Concord Medical Services Holdings' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Concord Medical Services Holdings (FRA:C2C), the current 3-1 Month Momentum % is N/A% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued.
The current stock price of €6.25 is trading 34.3% below its estimated GF Value™ of €9.51.
Key valuation signals for FRA:C2C:
3-1 Month Momentum %: N/A%
GF Value™: €9.51 vs. price of €6.25 (34.3% below fair value)
No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
49GF Score
Get the complete analysis for FRA:C2C
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:C2C has been successfully added to your 
